Results 71 to 80 of about 23,613 (235)

La dialyse péritonéale en soins intensifs : perspectives historiques et contemporaines après la pandémie de COVID-19

Bulletin de la Dialyse à Domicile
La dialyse péritonéale (DP) est utilisée depuis 1946 comme traitement de l’insuffisance rénale aiguë (IRA). Malgré un recul face aux techniques extracorporelles dans les pays à hauts revenus, elle connaît un regain d’intérêt, grâce notamment à son ...
Lucas Jacobs, Maxime Taghavi, Jabber Laouni, Adrien Lengelé, Mohamed Tayeb Salaouatchi, Karlien François, Michelle Coureau, Giuseppe Gambino, Anne-Lorraine Clause   +8 more
doaj   +1 more source

Preoxygenation in difficult airway management: high-flow oxygenation by nasal cannula versus face mask (the PREOPTIDAM study). Protocol for a single-centre randomised study

BMJ Open, 2019
Introduction Although preoxygenation and airway management respond to precise algorithms, difficult intubation (DI) remains a daily challenge in intensive care units and in the operating rooms because of its frequent complications, including hypoxaemia ...
Samir Jaber, Karim Asehnoune, Fanny Feuillet, Mickael Vourc’h, Donatien Huard, Gabrielle Baud, Arthur Guichoux, Marielle Surbled, Melanie Tissot, Anne Chiffoleau, Christophe Guitton   +10 more
doaj   +1 more source

La lutte contre la pauvreté à l'épreuve des essais cliniques. Réflexion sur l'approche expérimentale de l'économie du développement

, 2014
URL des Documents de travail : http://ces.univ-paris1.fr/cesdp/cesdp2014.htmlDocuments de travail du Centre d'Economie de la Sorbonne 2014.26 - ISSN : 1955-611XBy trying to guarantee that the fight against poverty is based on evidence, randomized ...
Favereau, Judith
core   +1 more source

Granulysin Antimicrobial Activity Promotes Dormancy in Mycobacterium tuberculosis

European Journal of Immunology, Volume 55, Issue 8, August 2025.
Exploiting a high‐dimensional mass cytometry approach, we demonstrate that CD56+ lymphocytes promote Mycobacterium tuberculosis dormancy by delivering granulysin, a cytotoxic effector molecule with known antimicrobial activity. ABSTRACT Human tuberculosis (TB) caused by Mycobacterium tuberculosis (Mtb) remains a global public health threat.
Sarah Schmidiger, Erin F. McCaffrey, Jan M. Schmidt, Owais Abdul Hameed, Max Mpina, Anneth Tumbo, Elirehema Mfinanga, Frederick Haraka, Hellen Hiza, Mohamed Sasamalo, Jerry Hella, Michael Walch, Jacques Fellay, Sébastien Gagneux, Klaus Reither, José M. Carballido, Ainhoa Arbués, Damien Portevin   +17 more
wiley   +1 more source

Médicaments orphelins : un statut particulier? [PDF]

, 2005
[...] Les maladies dites rares sont celles qui touchent un nombre restreint de personnes en regard de la population générale. Le seul de prévalence qui définit une maladie rare varie selon les pays; aux USA, il est par exemple inférieur à 200'000 cas, ce
Vidoudez, Martine
core  

GMP‐Compliant Process for the Manufacturing of an Extracellular Vesicles‐Enriched Secretome Product Derived From Cardiovascular Progenitor Cells Suitable for a Phase I Clinical Trial

Journal of Extracellular Vesicles, Volume 14, Issue 8, August 2025.
ABSTRACT Extracellular vesicle (EV)‐enriched secretomes are emerging as a new and innovative therapeutic option in the field of regenerative medicine. The clinical use of EV‐enriched secretome‐based products requires manufacturing processes and quality control (QC) testing that comply with current good manufacturing practice (GMP).
Camille Humbert, Chloé Cordier, Iouri Drut, Michele Hamrick, Jacquelyn Wong, Valérie Bellamy, Justine Flaire, Kiranmayee Bakshy, Florent Dingli, Damarys Loew, Jérôme Larghero, Jean‐Roch Fabreguettes, Philippe Menasché, Nisa K. Renault, Guillaume Churlaud   +14 more
wiley   +1 more source

Antithrombotic Therapy in Patients With Atrial Fibrillation and Coronary Artery Disease With Recent or Remote Events: Systematic Review and Meta-analysis

CJC Open
Background: Ongoing debate remains regarding optimal antithrombotic therapy in patients with atrial fibrillation (AF) and coronary artery disease. Methods: We performed a systematic review and meta-analysis to synthesize randomized controlled trials ...
Ahmad Hayek, MD, Blair J. MacDonald, BA PharmD, Guillaume Marquis-Gravel, MD, MSc, Kevin R. Bainey, MD, MSc, Samer Mansour, MD, Margaret L. Ackman, PharmD, Warren J. Cantor, MD, Ricky D. Turgeon, BSc(Pharm), PharmD   +7 more
doaj   +1 more source

Preliminary Study of a Degenerated Tricuspid Bioprosthetic Valve Implanted via Transcatheter Valve-in-Valve Implantation Guided by 3-Dimensional Printing

CJC Open
Background: The procedures of transcatheter tricuspid valve-in-valve (TTViV) replacement are challenging, and the clinical outcomes are still unclear.
Yu Mao, PhD, MD, Yanyan Ma, PhD, Mengen Zhai, PhD, MD, Lanlan Li, PhD, Ping Jin, PhD, MD, Yang Liu, PhD, MD, Jian Yang, PhD, MD   +6 more
doaj   +1 more source

[A global core outcome measurement set for snakebite clinical trials]. [PDF]

Med Trop Sante Int, 2023
Abouyannis M, Esmail H, Hamaluba M, Ngama M, Mwangudzah H, Mumba N, Yeri BK, Mwalukore S, Alphan HJ, Aggarwal D, Alcoba G, Cammack N, Chippaux JP, Coldiron ME, Gutiérrez JM, Habib AG, Harrison RA, Isbister GK, Lavonas EJ, Martins D, Ribeiro I, Watson JA, Williams DJ, Casewell NR, Walker SA, Lalloo DG.   +25 more
europepmc   +1 more source

Antidépresseurs et syndrome d'interruption [PDF]

, 2013
peer ...
PITCHOT, William
core